库欣综合征诊疗挑战:评估LC-MS/MS作为尿游离皮质醇确认方法
本研究开发并表征了基于液液萃取的LC-MS/MS定量方法,建立人群参考范围(4-41 µg/day),并评估其与免疫法(IA)在库欣综合征诊断和随访中的一致性。IA测得的UFC值显著高于LC-MS/MS,LC-MS/MS临床敏感性更高,支持将其作为临床实验室确认程序。
要点
- IA测定的UFC值显著高于LC-MS/MS,需建立方法特异性参考范围。
- LC-MS/MS对库欣综合征诊断/随访的临床敏感性高于IA。
- LC-MS/MS可识别IA的假阴性和假阳性结果,尤其IA未检出时。
核心结论
- LC-MS/MS作为UFC确认方法可提高库欣综合征诊断和随访的临床敏感性。
研究设计与样本
- 开发并全面表征基于液液萃取的LC-MS/MS定量方法,建立人群参考范围,并在库欣综合征随访或临床怀疑高皮质醇血症患者中评估与IA的一致性。
主要发现
- IA测定的UFC值显著高于LC-MS/MS。
- LC-MS/MS的人群参考范围为4-41 µg/day。
- 除IA未检出结果外,LC-MS/MS与IA的UFC值高度一致。
- 观察到IA潜在的假阴性和假阳性结果。
- LC-MS/MS对库欣综合征诊断/随访的临床敏感性高于IA。
关键数值与推荐
- LC-MS/MS法UFC参考范围:4-41 µg/day。
临床怎么用
- 在临床实验室中采用LC-MS/MS作为UFC的确认程序,以辅助库欣综合征的诊断和随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
24-h urinary free cortisol (UFC) measurements are fundamental in the diagnosis and follow-up of Cushinǵs syndrome (CS) and immunoassays (IA) are the most widely used tests for its quantification in clinical laboratory practice. However, their suitability has been questioned mainly due to their limitations concerning analytical specificity. The aim of this research project was to evaluate a novel algorithm for CS diagnosis and follow-up in the clinical laboratory, based on the combination of IA tests with liquid chromatography-tandem mass spectrometry (LC-MS/MS) for UFC quantification. A quantitative LC-MS/MS approach based on liquid-liquid extraction for sample preparation was developed and fully characterized. A population-based reference range was established and the level of agreement for UFC values when compared to IA approach was assessed in patients under CS follow-up or clinical suspicion for hypercortisolism. Significantly higher UFC values were observed for IA when compared to LC-MS/MS approach, therefore population-based reference range was established for the latter (i.e. 4 - 41 µg/day). The clinical application of the herein presented LC-MS/MS approach to be used as a confirmation procedure for CS management was assessed and a high level of agreement with IA UFC values, except in the case of IA undetectable results, was observed. However, IA potential false negative (FN) and false positive (FP) findings were also noted. Higher clinical sensitivity for CS diagnosis / follow-up was observed for LC-MS/MS when compared to IA, supporting the advantage and necessity of implementing LC-MS/MS as a confirmation procedure in the clinical laboratory.
引用
- Rubio A, Tofé S, Elorza MA, et al. Challenges in the diagnosis and follow-up of Cushing's syndrome: Evaluating LC-MS/MS as a confirmation method for urinary free cortisol analyses. Clin Chim Acta. 2025. PMID: 39809375. doi:10.1016/j.cca.2025.120129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。